Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CGTX
COGNITION THERAPEUTICS, INC.
NASDAQ
$1.02
▼ DOWN 3.77% (-0.04)

KEY STATISTICS

Market Cap$91.29 M
52w High$2.67
52w Low$0.55
Dividend Yield—
Frequency—
P/E-4.25
Volume343.62K
Shares Out.89.50M

COMPANY

LEADERSHIP

Lisa Ricciardi
CHIEF EXECUTIVE
Lisa Ricciardi

COMPENSATION 2026

Salary$651,015
Stock Awards$396,456
Incentive Plan Pay$393,864
All Other Comp.$18,300
Total$1,459,635

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 8, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
14

PRICE TARGET

Target High$3.00
Target Low$3.00
Target Median$3.00
Target Consensus$3.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$5.30M
NOV
5
THU

PRICE

$1.02 ▼ DOWN 3.77% (−$0.04)
$1.02$1.03$1.05$1.069:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1.02

About Cognition Therapeutics, Inc.

https://www.cogrx.com ↗

Cognition Therapeutics, Inc. is a clinical-stage biopharma developing small molecule therapies, including CT1812 for Alzheimer's and DLB, with ongoing trials for age-related neurodegenerative and retinal diseases.

INDUSTRY

Biotechnology

A PRODUCT COGNITION THERAPEUTICS, INC. IS KNOWN FOR

CT1812 (zervimesine)
CT1812 (zervimesine)

CT1812 (zervimesine) is an investigational oral small-molecule drug by Cognition Therapeutics targeting sigma-2 receptors to potentially slow neurodegenerative diseases like Alzheimer's and dementia with Lewy bodies.

COMPETITORS

COMPETITOR
ACIU COMPARE
AVXL COMPARE
BIIB COMPARE
LLY COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
13
LISTED HERE
2
RANKED BY POSITION SIZE
VTI
0.00% · 2.4M
IWC
0.02% · 278.9K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
26.09%
HOLDERS
107
TOP 12 OF 107 · RANKED BY POSITION SIZE
Bios Capital Management, LP
6.0M sh · $4.56M
Davenport & Co LLC
4.3M sh · $4.9M
Vanguard Group Inc
3.3M sh · $4.48M
Pathstone Family Office, LLC
2.2M sh · $3.18M
Blackrock, Inc.
1.3M sh · $1.45M
Tang Capital Management LLC
1.2M sh · $1.62M
Renaissance Technologies LLC
1.1M sh · $848.47K
Chescapmanager LLC
997.0K sh · $1.35M
Jane Street Group, LLC
926.1K sh · $1.25M
Geode Capital Management, LLC
920.2K sh · $699.23K
Hilton Capital Management, LLC
581.1K sh · $784.55K
Millennium Management LLC
560.6K sh · $756.75K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

★
DIRECTOR, 10 PERCENT OWNER:
Fletcher Aaron G.L.
Purchase · 25.0K shares
2026-06-17
★
DIRECTOR
Wallace Peggy
Purchase · 25.0K shares
2026-06-17
★
DIRECTOR
RICHSTONE ELLEN B
Purchase · 25.0K shares
2026-06-17
★
DIRECTOR
Monia Brett P
Purchase · 25.0K shares
2026-06-17

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
3 GRADES IN THE LAST 12 MONTHS
Chardan Capital BUY HC Wainwright & Co. BUY B. Riley Securities BUY

SECTORS PEERS

PEERPRICE
AGEN$7.66COMPARE
IRD$3.69COMPARE
GLSI$15.67COMPARE
SRZN$22.42COMPARE
SEER$1.98COMPARE
SPRO$1.20COMPARE
MCRB$5.11COMPARE
TVGN$6.89COMPARE